First Round of abstract submission : February 15, 2018 | Welcome Message

Theme : Novel Trends and Innovations in Biotechnology

Organizing Committee Members

ABOUT CONFERENCE

Science Access invites all the professors, delegates, researchers, experts to attend “International Conference on Biotechnology & Industrial Revolution” during June 25-27, 2018 Rome, Italy. The Biotechnology gatherings intend to investigate the crown examines in the tremendous field of science and united sciences. Science being the premise of life is a necessary part in each unique science from Life science to Rocket Science. These looks into when talked about can illuminate numerous youthful personalities in performing greater quality arranged research.

Biotechnology Conference 2018 gives an immaculate stage to bring out such quality research works. These gatherings are stretched out by commenting key administrative ranges like Multi-disciplinary biotechnology. Giving a possibility, Science Access biotechnology Conferences have researchers, analysts, substance associations and all agents of pharmaceutical and science organization divisions can exhibit their apt discoveries and in the meantime get presented to a helpful cluster of research and most recent improvements. To talk about the issues and achievements in the field of Biotechnology Science Access Conferences has taken the start to accumulate the world-class specialists both from scholastic and industry in a typical stage at its Biotechnology meetings with the Theme: Novel Trends and Innovations in Biotechnology.

Key Market  Analysis

The importance of the biotech industry to growth and competitiveness in Europe is clear: it is recognized as a Key Enabling Technology (KET) under skyline 2020 as a means to boost technological innovation and industrial leadership. Today, the majority of contemporary medicines as well as many diagnostic products is developed or manufactured using biotechnology. Globally, biotech medicines represent 20% of commercialized drugs, 40% of authorized drugs and 50% of drugs under development. In Italy, there are already 110 biotech drugs available.

In recent years, the biotech industry in Italy has developed due to excellent academic and industrial research as well as the value of the technology and products developed. Italian biotech companies totaled 489 in 2015. The turnover is over $11.6 billion, while investments in R&D amounted to $2 billion with about 3,670 employees in research. Biotechnology is between the sectors with the higher innovation in Italy.

The red biotech (life sciences) sector in Italy, as in other countries, is the most developed and accounts for the largest number of companies (53%), comprising 261 of the total 489 firms. Pharmaceutical and medical devices biotech firms (75%) are responsible for much of the turnover, with an increased number of projects both in diagnosis and therapies. There are about 100 laboratories (public research centers and university labs), 47 Scientific and  Research Hospitals(IRCCS) and around 200 companies. These red biotech companies employ over 2900 people. The development of this sector will represent a great opportunity for major U.S.biotech companies looking for partnership to advance new treatments and product development.

According to the 2016 report by Centro Studi Assobiotec, the Italian biotech industry is anticipated to grow significantly in the coming years. Industry experts expect revenue to grow by 12.8% in 2017 and 18% in 2019, confirming the significant contribution that new technologies and products will bring in the coming years. At the same time Italy depend on biotech drug imports primarily from the United States, Belgium, and Germany.

Italian biotech companies are primarily concentrated in the following areas: oncology, infectious diseases, inflammatory disease, neurological disease and cardiovascular diseases. Recent reemergence of infectious diseases and epidemic outbreaks such as Ebola have oriented investments towards vaccines and new drugs. In fact, the World Health Organization has selected an Italian vaccine to fight the Ebola epidemic.

KEY MARKET BENEFITS

Biotechnology is useful in the biological processes organisms or system to manufacture products are calculated to improve the quality of human life.The earliest biotechnologists were farmers who developed improved species of plants and animals by cross pollenization or cross breeding.

The scientific session of biotechnology can be divided into subdisciplines called red, white, green, and blue.Blue biotechnology mentioned in encompasses processes in marine and aquatic environments, such as controlling the proliferation of noxious water-borne organisms.

Biotechnology like other advanced technologies, has the potential for misuse. Concern about this has led to efforts by some groups to approve legislation restricting or banning certain processes or programs, such as human cloning and embryonic stem-cell research. There is also concern that if biotechnological processes are used by groups with nefarious intent, the end result could be biological warfare.

Organizations

Biotechnology Innovation Organization

European Biotechnology Association

Agri Biotech Foundation

International Centre for Genetic Engineering and Biotechnology

Earlham Institute

The Gilead Sciences Foundation

North Carolina Biotechnology Center

Genentech Foundation

 

biotech@scienceaccess.net

biotech@scienceaccess.co.uk

 

Innovative nursing Conferences
Innovinc nursing Conferences

Target Audience

  • Presidents & CEO’s
  • Students
  • Scientists
  • Biotechnologists
  • Research Scholars
  • Pharmaceutical Experts
  • Microbiologists
  • Biological Enginners
  • Forensic Biologists

Contact Us

Feel Free To Contact Us

Address   : 2737 Live Oak Street, Huntington Park, CA 90255, USA
Phone No : +1 - 267-646-2200 ; +1 -302-428-9993
Fax           : +1 - 267-646-2200
Email Id    : biotech@scienceaccess.co.uk


MAIL US AT

Subscribe
 

Authorization Policy: By registering for the conference you grant permission to SCIENCEACCESS to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or video recording by participants/others during conference is prohibited without prior approval. Contact us for any queries. Privacy is Everyone's Concern!